Working to push forward revolutionary therapies to treat uro-gynecologics pathologies
CAMATISS is at the forefront of biotechnology research, dedicated to developing revolutionary therapies for uro-gynecologic pathologies. CAMATISS is focused on innovation, particularly in creating advanced solutions for prevalent conditions affecting women's health.
The CAMATISS project is developing a new generation of mesh designed to treat Pelvic Organ Prolapse (POP), a condition affecting a significant portion of women. Addressing the critical need for safe and effective medical devices, CAMATISS aims to provide a biological and human mesh that offers a real solution for patients, ensuring enhanced quality of life and improved medical outcomes.
With a commitment to excellence and innovation, CAMATISS is poised to make a significant impact in the field of uro-gynecology. Located in Bordeaux, FR, CAMATISS is dedicated to advancing medical solutions through cutting-edge research and development. We invite the management team at CAMATISS to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.
Other organizations in the same industry
This company is also known as